...
首页> 外文期刊>BMJ: British medical journal >Corticosteroids in acute traumatic brain injury: systematic review of randomised controlled trials
【24h】

Corticosteroids in acute traumatic brain injury: systematic review of randomised controlled trials

机译:糖皮质激素在急性创伤性脑损伤:随机对照试验的系统评价

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective: To quantify the effectiveness and safety of corticosteroids in the treatment of acute traumatic brain injury. Design: Systematic review of randomised controlled trials of corticosteroids in acute traumatic brain injury. Summary odds ratios were estimated as an inverse variance weighted average of the odds ratios for each study. Setting: Randomised trials available by March 1996. Subjects: The included trials with outcome data comprised 2073 randomised participants. Results: The effect of corticosteroids on the risk of death was reported in 13 included trials. The pooled odds ratio for the 13 trials was 0.91 (95% confidence interval 0.74 to 1.12). Pooled absolute risk reduction was 1.8% (- 2.5% to 5.7%). For the 10 trials that reported death or disability the pooled odds ratio was 0.90 (0.72 to 1.11). For infections of any type the pooled odds ratio was 0.92 (0.69 to 1.23) and for the seven trials reporting gastrointestinal bleeding it was 1.05 (0.44 to 2.52). With only those trials with the best quality of concealment of allocation, the pooled odds ratio estimates for death and death or disability became closer to unity. Conclusions: This systematic review of randomised controlled trials of corticosteroids in acute traumatic brain injury shows that there remains considerable uncertainty over their effects. Neither moderate benefits nor moderate harmful effects can be excluded. The widely practicable nature of the drugs and the importance of the health problem suggest that large simple trials are feasible and worth while to establish whether there are any benefits from use of corticosteroids in this setting.
机译:摘要目的:量化和有效性糖皮质激素治疗的安全急性创伤性脑损伤。审查的随机对照试验糖皮质激素在急性创伤性脑损伤。总结优势比估计作为一个逆方差加权平均优势比每一个研究。1996年3月。结果数据由2073个随机参与者。糖皮质激素对死亡的风险报告在13个包括试验。13个试验为0.91(95%置信区间0.74到1.12)。1.8%(5.7% - 2.5%)。报告死亡或残疾的汇集比率为0.90(0.72 - 1.11)。任何类型的集中优势比为0.92 (0.691.23)和七个试验报告消化道出血是1.05 (0.442.52)。分配的隐藏质量,汇集优势比估计死亡和死亡或残疾成为接近统一。随机控制的系统评价糖皮质激素在急性创伤性的试验脑损伤显示仍然存在相当大的不确定性的影响。无论是温和的好处还是温和的有害的影响可以被排除在外。药物和性质的重要性健康问题表明,大型简单的试验是可行的,是否值得从使用有任何好处糖皮质激素在此设置。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号